Involved-field radiation therapy for inoperable non small-cell lung cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Clinical Oncology

• Publication date

  2007-12-10

• Fields of study

  Medicine

• Identifiers
  DOI 10.1200/JCO.2007.13.2191PMID 17984185
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located.

  2007cited by this paper
• Three-dimensional conformal involved-field radiotherapy for stage III non-small cell lung cancer.

  2006cited by this paper
• Exclusion of Elective Nodal Irradiation Does Not Decrease Local Regional Control of Non-Small Cell Lung Cancer

  2005cited by this paper
• Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.

  2005cited by this paper
• Results of a phase I dose‐escalation study using three‐dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma

  2005cited by this paper
• Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)?

  2004cited by this paper
• Elective nodal failures are uncommon in medically inoperable patients with Stage I non-small-cell lung carcinoma treated with limited radiotherapy fields.

  2003cited by this paper
• The impact of regional nodal radiotherapy (dose/volume) on regional progression and survival in unresectable non-small cell lung cancer: an analysis of RTOG data.

  2003cited by this paper
• Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy.

  2002cited by this paper
• Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

  2002cited by this paper
• Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy.

  2001cited by this paper
• Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial.

  2001cited by this paper
• Involved-field radiotherapy alone for early-stage non-small-cell lung cancer.

  2000cited by this paper
• Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer.

  2000cited by this paper
• Assessing the impact of elective regional radiotherapy on survival.

  1999cited by this paper
• Hyperfractionated radiotherapy for clinical stage II non-small cell lung cancer.

  1999cited by this paper
• Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer.

  1999cited by this paper
• 186 Incidental dose to clinically negative nodes from conformal treatment fields for nonsmall cell lung cancer

  1999cited by this paper
• 123 The toxicity of elective nodal irradiation in the definitive treatment of non-small cell carcinoma of the lung

  1997cited by this paper
• Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer.

  1997cited by this paper
• Fitting of normal tissue tolerance data to an analytic function.

  1991cited by this paper
• Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations.

  1991cited by this paper
• Dose computations for three-dimensional radiation treatment planning.

  1989cited by this paper
• Treatment volume and tissue tolerance.

  1988cited by this paper
• A comprehensive three-dimensional radiation treatment planning system.

  1988cited by this paper
• Long‐term observations of the patterns of failure in patients with unresectable non‐oat cell carcinoma of the lung treated with definitive radiotherapy report by the radiation therapy oncology group

  1987cited by this paper
• Principles and Practice of Radiation Oncology

  1987cited by this paper
• Complication Probability as Assessed from Dose-Volume Histograms

  1985cited by this paper
• Nonparametric Estimation from Incomplete Observations

  1958cited by this paper

• Current Approaches to Radiation Oncology Target Volume Delineation Using PET/Computed Tomography.

  2025cites this paper
• Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial.

  2025cites this paper
• A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.

  2024cites this paper
• Radiation therapy with phenotypic medicine: towards N-of-1 personalization

  2024cites this paper
• High-risk patients with locally advanced non-small cell lung cancer treated with stereotactic body radiation therapy to the peripheral primary combined with conventionally fractionated volumetric arc therapy to the mediastinal lymph nodes

  2023cites this paper
• Efficacy and quality-of-life following involved nodal radiotherapy for head and neck squamous cell carcinoma: the INRT-AIR phase II clinical trial.

  2023cites this paper
• Locally advanced NSCLC: a plea for sparing the ipsilateral normal lung—prospective, clinical trial with DART-bid (dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily) by VMAT

  2022cites this paper
• Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer—a two center experience

  2021influential citation
• Nodal metabolic tumour volume on baseline 18F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy

  2021cites this paper
• Involved-Field Irradiation in Definitive Chemoradiotherapy for Locoregional Esophageal Squamous Cell Carcinoma: Results from the ESO-Shanghai 1 Trial.

  2021cites this paper
• Interactions Between Dose and Volume in Chemoradiotherapy of Esophageal Cancer.

  2021cites this paper
• Concurrent chemoradiotherapy for stage III non-small-cell lung cancer: recent progress and future perspectives (a narrative review)

  2021cites this paper
• Could the clinical target volume be omitted for radiotherapy of locally advanced non-small cell lung cancer in the modern era?

  2021cites this paper
• Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer

  2020cites this paper
• Lung Cancer in Older Adults: Local Treatment

  2020cites this paper
• Radiotherapy for unresectable locally advanced non-small cell lung cancer: a narrative review of the current landscape and future prospects in the era of immunotherapy

  2020cites this paper
• Definitive Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer: Current Status and Future Perspectives

  2020cites this paper
• Comparison of Involved Field Radiotherapy versus Elective Nodal Irradiation in Stage IIIB/C Non-Small-Cell Lung Carcinoma Patients Treated with Concurrent Chemoradiotherapy: A Propensity Score Matching Study

  2020cites this paper
• Postoperative Radiotherapy for Locally Advanced NSCLC: Implications for Shifting to Conformal, High-Risk Fields.

  2020cites this paper
• Alternative Multidisciplinary Management Options for Locally Advanced Non-Small Cell Lung Cancer During the COVID-19 Global Pandemic

  2020cites this paper
• Less is more? Imaging-based target volume reduction.

  2020cites this paper
• Alternative Multidisciplinary Management Options for Locally Advanced NSCLC During the Coronavirus Disease 2019 Global Pandemic

  2020cites this paper
• The Role of Positron Emission Tomography Imaging in Radiotherapy Target Delineation.

  2020cites this paper
• PET/CT in der Strahlentherapie

  2020cites this paper
• Differential Relapse Patterns for Non-small Cell Lung Cancer Subtypes Adenocarcinoma and Squamous Cell Carcinoma: Implications for Radiation Oncology.

  2019cites this paper
• Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy.

  2019cites this paper
• Using 18F-FDG PET/CT to Diagnose and Treat Non-small Cell Lung Cancer

  2019cites this paper
• Management of Locally Advanced Lung Cancer

  2019cites this paper
• Salvage Therapy for Locoregional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.

  2019cites this paper
• ICORG 06-35: a prospective evaluation of PET-CT scan in patients with non-operable or non-resectable non-small cell lung cancer treated by radical 3-dimensional conformal radiation therapy: a phase II study

  2019cites this paper
• [Lung cancer and elective nodal irradiation: A solved issue?]

  2019cites this paper
• Advanced radiation techniques for locally advanced non-small cell lung cancer: intensity-modulated radiation therapy and proton therapy.

  2018cites this paper
• The dosimetric effects of limited elective nodal irradiation in volumetric modulated arc therapy treatment planning for locally advanced non-small cell lung cancer

  2018cites this paper
• Non-small Cell Lung Cancer

  2018cites this paper
• Preliminary Results about Application of Intensity-Modulated Radiotherapy to Reduce Prophylactic Radiation Dose in Limited-Stage Small Cell Lung Cancer

  2018cites this paper
• The importance of quality and consistent target volume definition in the treatment of locally advanced non-small cell lung cancer

  2018cites this paper
• Use of PET and Other Functional Imaging to Guide Target Delineation in Radiation Oncology.

  2018cites this paper
• Two Decades of (Mostly) Disappointments in Definitive Chemoradiation for Stage III Non-Small Cell Lung Cancer

  2018cites this paper
• Commentary: Radiotherapy Innovations-New Horizons for Cancer Care

  2017cites this paper
• Clinical outcomes using carbon-ion radiotherapy and dose-volume histogram comparison between carbon-ion radiotherapy and photon therapy for T2b-4N0M0 non-small cell lung cancer—A pilot study

  2017cites this paper
• Recent Developments in Radiotherapy

  2017cites this paper
• Incidental nodal irradiation in locally advanced non-small cell lung cancer treated with involved-field IMRT

  2017cites this paper
• Image guided radiotherapy may result in improved local control in locally advanced lung cancer patients

  2017cites this paper
• Sites of recurrent disease and prognostic factors in SCLC patients treated with radiochemotherapy

  2017cites this paper
• Guidelines for the Delineation of Lymphatic Target Volumes in Lung Cancer

  2016cites this paper
• Early lesion-specific (18)F-FDG PET response to chemotherapy predicts time to lesion progression in locally advanced non-small cell lung cancer.

  2016cites this paper
• IMRT and 3D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC

  2016cites this paper
• Involved field radiotherapy (IFRT) versus elective nodal irradiation (ENI) for locally advanced non-small cell lung cancer: a meta-analysis of incidence of elective nodal failure (ENF)

  2016cites this paper
• PET-Based Thoracic Radiation Oncology.

  2016cites this paper
• Chapter 44 – Non–Small Cell Lung Cancer

  2016cites this paper
• Involved-field radiotherapy for esophageal squamous cell carcinoma: theory and practice

  2016cites this paper
• Image guided radiation therapy may result in improved local control in locally advanced lung cancer patients.

  2016cites this paper
• [Role of functional imaging in the definition of target volumes for lung cancer radiotherapy].

  2016cites this paper
• Radiothérapie et traitements combinés des cancers bronchiques non à petites cellules localement avancés

  2016cites this paper
• IMRT and 3 D conformal radiotherapy with or without elective nodal irradiation in locally advanced NSCLC A direct comparison of PET-based treatment planning

  2016cites this paper
• Is a Clinical Target Volume (CTV) Necessary in the Treatment of Lung Cancer in the Modern Era Combining 4-D Imaging and Image-guided Radiotherapy (IGRT)?

  2016cites this paper
• Involved-field Radiation Therapy for Patients with Stage III Non-small-cell Lung Cancer: Early Results of Hypofractionated Involved-field Radiation Therapy

  2016cites this paper
• Lung cancer radiation therapy: Defining optimal evidence-based treatment approaches

  2016cites this paper
• Phase II trial of recombinant human endostatin in combination with concurrent chemoradiotherapy in patients with stage III non-small-cell lung cancer.

  2015cites this paper
• A Validated Prediction Model for Overall Survival From Stage III Non-Small Cell Lung Cancer: Toward Survival Prediction for Individual Patients

  2015cites this paper
• A Predictive Model for Lymph Node Involvement with Malignancy on PET/CT in Non–Small-Cell Lung Cancer

  2015cites this paper
• DART-bid: dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily

  2015cites this paper
• Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis

  2015cites this paper
• Utility of PET for Radiotherapy Treatment Planning.

  2015cites this paper
• Intensity-modulated proton therapy for elective nodal irradiation and involved-field radiation in the definitive treatment of locally advanced non-small-cell lung cancer: a dosimetric study.

  2015cites this paper
• PET-CT use and the occurrence of elective nodal failure in involved field radiotherapy for non-small cell lung cancer: A systematic review.

  2015cites this paper
• Whole Pelvis Versus Prostate-Only Radiotherapy With or Without Short-Course Androgen Deprivation Therapy and Mortality Risk.

  2015cites this paper
• Target Volume Delineation for Conformal and Intensity-Modulated Radiation Therapy

  2015cites this paper
• Improved inter-observer agreement of an expert review panel in an oncology treatment trial--Insights from a structured interventional process.

  2015cites this paper
• The Role of IMRT in Lung Cancer : Guideline Recommendations

  2015cites this paper
• Role of radiation therapy in the management of stage III non-small cell lung cancers: current status and controversies

  2015cites this paper
• Advances in Radiotherapy for Locally Advanced NSCLC

  2015cites this paper
• Non-small cell lung cancer, version 1.2015.

  2014cites this paper
• [Lung cancer: progress in diagnosis and treatments. Topics: III. Treatment; 2. The role of radiation therapy for lung cancer].

  2014cites this paper
• Combinations of Radiation Therapy and Chemotherapy for Non-Small Cell and Small-Cell Lung Carcinoma

  2014cites this paper
• 2．肺癌：放射線治療

  2014cites this paper
• Locally Advanced Non-Small Cell Lung Cancer and Small Cell Lung Cancer

  2014cites this paper
• Patterns of locoregional failure in stage III non-small cell lung cancer treated with definitive chemoradiation therapy.

  2014cites this paper
• Simultaneous integrated boost intensity-modulated radiotherapy for treatment of locally advanced non-small-cell lung cancer: a retrospective clinical study.

  2014cites this paper
• Increase in cell motility by carbon ion irradiation via the Rho signaling pathway and its inhibition by the ROCK inhibitor Y-27632 in lung adenocarcinoma A549 cells

  2014cites this paper
• Strategies of Dose Escalation in the Treatment of Locally Advanced Non-Small Cell Lung Cancer: Image Guidance and Beyond

  2014cites this paper
• Patterns of practice in radiation therapy for non-small cell lung cancer among members of the American Society for Radiation Oncology.

  2014cites this paper
• Impact of irradiation protocol deviations on the outcome of unresectable stage III NSCLC patients receiving concurrent chemoradiotherapy: Quality-assurance results of the GFPC-IFCT 02.01 trial

  2014cites this paper
• NCCN Guidelines Version 1.2015 Panel Members Non-Small Cell Lung Cancer

  2014cites this paper
• High Dose Conformal Radiotherapy in Stage III Non-Small Cell Lung Cancer : A Feasibility Study

  2014cites this paper
• Role of stereotactic body radiation therapy and proton/carbon nuclei therapies.

  2013influential citation
• Effect of induction chemotherapy on estimated risk of radiation pneumonitis in bulky non-small cell lung cancer.

  2013cites this paper
• DART-bid (Dose-differentiated accelerated radiation therapy, 1.8 Gy twice daily)–a novel approach for non-resected NSCLC: final results of a prospective study, correlating radiation dose to tumor volume

  2013cites this paper
• Proton Beam Therapy for Lung Cancer

  2013cites this paper
• Non-small Cell Lung Cancer (NSCLC) and Small Cell Lung Cancer (SCLC)

  2013cites this paper
• Fluorodeoxyglucose positron-emission tomography ratio in non-small cell lung cancer patients treated with definitive radiotherapy

  2013cites this paper
• Labeled MaB (Labeled Monoclonal Antibodies)

  2013cites this paper
• [National consensus of diagnosis and treatment of non-small cell lung cancer].

  2013cites this paper
• Radiotherapy for Postoperative Thoracic Lymph Node Recurrence of Non–Small-Cell Lung Cancer Provides Better Outcomes If the Disease Is Asymptomatic and a Single-Station Involvement

  2013cites this paper
• Acute Radiation Esophagitis Caused by High-Dose Involved Field Radiotherapy with Concurrent Cisplatin and Vinorelbine for Stage III Non-small Cell Lung Cancer

  2013cites this paper
• Involved-Field Radiotherapy versus Elective Nodal Irradiation in Combination with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Prospective Randomized Study

  2013cites this paper
• [Target volume margins for lung cancer: internal target volume/clinical target volume].

  2013cites this paper
• Motion-specific internal target volumes for FDG-avid mediastinal and hilar lymph nodes.

  2013cites this paper
• Non-small Cell Lung Cancer

  2013cites this paper
• Patterns of regional failure in stage III non-small cell lung cancer treated with neoadjuvant chemoradiation therapy and resection.

  2013cites this paper